0

Bioprocess Technology Market by End-user and Geography - Forecast and Analysis 2022-2026

  • Published: Jul 2022
  • Pages: 127
  • SKU: IRTNTR73957
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The bioprocess technology market share is expected to increase to USD 55.84 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 12.27%.

This bioprocess technology market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers bioprocess technology market segmentation by end-user (biopharmaceutical companies, contract manufacturing organizations, academic research institute, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The bioprocess technology market report also offers information on several market vendors, including Advanced Instruments LLC, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Catalent Inc., Charles River Laboratories International Inc., Corning Inc., Dover Corp., Emerson Electric Co., Fujifilm Diosynth Biotechnologies USA Inc., General Electric Co., Koninklijke Philips NV, Lonza Group Ltd., Merck KGaA, Nova Biomedical Corp., Repligen Corp., Sartorius AG, STADA Arzneimittel AG, Thermo Fisher Scientific Inc., Univercells SA, and Eppendorf AG among others.

What will the Bioprocess Technology Market Size be During the Forecast Period?

Bioprocess Technology Market Size

Download the Free Report Sample to Unlock the Bioprocess Technology Market Size for the Forecast Period and Other Important Statistics

 

Bioprocess Technology Market: Key Drivers, Trends, and Challenges

The increase in infectious diseases is notably driving the bioprocess technology market growth, although factors such as the lack of trained laboratory professionals may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the bioprocess technology industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Bioprocess Technology Market Driver

One of the key factors driving growth in the bioprocess technology market is the increase in infectious diseases. The prevalence of infectious diseases is increasing at a fast rate due to the growing global population. There have been several cases of diseases such as Ebola, severe acute respiratory syndrome (SARS), swine flu, Zika, and Lassa fever, which are considered global pandemics. During 2020-2021, a large population across the world was affected by COVID-19. Treating pandemic and epidemic infectious diseases require vaccines or drugs. This has led to the R and D of antiviral drugs, cell-based therapies, and vaccines using cell culture methods. Also, developing countries such as India, China, and the US are significantly investing in bioprocess technology. For instance, the Indian government planned to have 10,000 biotech start-ups by 2024 and a $150 billion bioeconomy by 2025. The growing investments and expansion in bioprocess technology across various regions will drive the growth of the market.

Key Bioprocess Technology Market Trend

The increasing clinical trials in countries is a bioprocess technology market trend that is expected to have a positive impact in the coming years. The globalization of clinical trials has consistently expanded over the past two decades, which has been credited to numerous components, including organized trials, voluntary members, accessibility of qualified local investigators, improved infrastructure facilities, and the low expense of clinical trials in developing nations such as India and China and also underdeveloped nations such as Bangladesh. The potential clinical advantages for disease-specific biomarkers incorporate faster and more accurate disease analysis and potential diminishing in sample size and time of clinical trials, which will accelerate drug development during the forecast period. The use of biomarkers in the clinical field of neurological disorders and others is expected to figure out whether a medication achieves its proposed target or changes the course of the disease. Thus, the increase in clinical trials will incorporate various bioprocess technology such as cell cultures, which, in turn, will drive the growth of the market in the region.

Key Bioprocess Technology Market Challenge

The lack of trained laboratory professionals will be a major challenge for the bioprocess technology market during the forecast period. Experiments involving bioprocess biotechnology require accurate analysis and interpretation of results for reliable results. The correlation of experimental results with the hypothesis of the experiment is crucial. Therefore, experiments involving bioprocess biotechnology must be performed by skilled personnel. As developing countries in Africa and South America lack adequately trained laboratory professionals, bioprocess biotechnology-based experiments are uncommon. Most laboratory technicians are unaware of the latest technologies in laboratory equipment and their benefits. The lack of expertise among skilled professionals in research laboratories can lead to misleading results. Thus, the shortage of trained professionals will affect the growth of the market during the forecast period.

This bioprocess technology market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global bioprocess biotechnology market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the bioprocess technology market during the forecast period.

Who are the Major Bioprocess Technology Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Advanced Instruments LLC
  • Becton Dickinson and Co.
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Corning Inc.
  • Dover Corp.
  • Emerson Electric Co.
  • Fujifilm Diosynth Biotechnologies USA Inc.
  • General Electric Co.
  • Koninklijke Philips NV
  • Lonza Group Ltd.
  • Merck KGaA
  • Nova Biomedical Corp.
  • Repligen Corp.
  • Sartorius AG
  • STADA Arzneimittel AG
  • Thermo Fisher Scientific Inc.
  • Univercells SA
  • Eppendorf AG

 

This statistical study of the bioprocess technology market encompasses successful business strategies deployed by the key vendors. The bioprocess technology market is fragmented and the vendors are deploying growth strategies such as increasing their R&D investments to compete in the market.

Product Insights and News

  • aicompanies.com - The company offers bioprocess technology such as OsmoTECH HT Automated Micro Osmometer and Solentim VIPS.

  • aicompanies.com - Under the unified segment, the company offers products such as osmometers, single cell ceder, dairy testing, reagents and controls.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The bioprocess technology market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Bioprocess Technology Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the bioprocess technology market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Bioprocess Technology Market?

Bioprocess Technology Market Share by Geography

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market’s growth will originate from North America during the forecast period. the US is the key market for bioprocess technology in North America. Market growth in this region will be faster than the growth of the market in the European and ROW regions.

The presence of major companies such as Becton, Dickinson and Co.(BD,) Danaher Corp. (Danaher), and Thermo Fisher Scientific, Inc. (Thermo Fisher Scientific) will facilitate the bioprocess technology market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

Due to the outbreak of COVID-19, research on bioprocess technologies such as cell-based therapies and the development of novel therapies for the treatment of COVID-19 have increased in the region, which is expected to contribute to the growth of the bioprocess biotechnology market in North America during the forecast period. The funding from different societies and private organizations promotes the US and Canada to focus on drug discovery and development for neurological disorders. Therefore, growing cell-based research and therapies in the region are expected to contribute to the growth of the bioprocess biotechnology market in the region during the forecast period.

What are the Revenue-generating End-user Segments in the Bioprocess Technology Market?

Bioprocess Technology Market Share

To gain further insights on the market contribution of various segments Request for a FREE sample

The bioprocess technology market share growth by the biopharmaceutical companies segment will be significant during the forecast period. In the past few years, there has been a significant increase in the demand for biopharmaceutical products, especially those extracted from mammalian cells. Such products speed up the recovery process, cure a wide range of diseases, have fewer side effects compared with conventional drugs, and allow clinicians to provide tailored treatment for specific medical issues for each patient. All these advantages have resulted in an increased preference for biopharmaceutical products and thus have led to a rise in biopharmaceutical companies.

This report provides an accurate prediction of the contribution of all the segments to the growth of the bioprocess technology market size and actionable market insights on post COVID-19 impact on each segment.

 

Bioprocess Technology Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 12.27%

Market growth 2022-2026

$ 55.84 billion

Market structure

Fragmented

YoY growth (%)

11.69

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Germany, UK, France, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Advanced Instruments LLC, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Catalent Inc., Charles River Laboratories International Inc., Corning Inc., Dover Corp., Emerson Electric Co., Fujifilm Diosynth Biotechnologies USA Inc., General Electric Co., Koninklijke Philips NV, Lonza Group Ltd., Merck KGaA, Nova Biomedical Corp., Repligen Corp., Sartorius AG, STADA Arzneimittel AG, Thermo Fisher Scientific Inc., Univercells SA, and Eppendorf AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Bioprocess Technology Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive bioprocess technology market growth during the next five years
  • Precise estimation of the bioprocess technology market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the bioprocess technology industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of bioprocess technology market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by End-user

    • 5.1 Market segments
      • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
    • 5.2 Comparison by End-user
      • Exhibit 26: Chart on Comparison by End-user
      • Exhibit 27: Data Table on Comparison by End-user
    • 5.3 Biopharmaceutical companies - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Biopharmaceutical companies - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 29: Data Table on Biopharmaceutical companies - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 30: Chart on Biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
    • 5.4 Contract manufacturing organizations - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Contract manufacturing organizations - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 33: Data Table on Contract manufacturing organizations - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 34: Chart on Contract manufacturing organizations - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Contract manufacturing organizations - Year-over-year growth 2021-2026 (%)
    • 5.5 Academic research institute - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Academic research institute - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 37: Data Table on Academic research institute - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 38: Chart on Academic research institute - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Academic research institute - Year-over-year growth 2021-2026 (%)
    • 5.6 Others - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.7 Market opportunity by End-user
      • Exhibit 44: Market opportunity by End-user ($ billion)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 46: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 48: Chart on Geographic comparison
      • Exhibit 49: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 France - Market size and forecast 2021-2026
      • Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
    • 7.11 China - Market size and forecast 2021-2026
      • Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
      • Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 86: Market opportunity by geography ($ billion)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 89: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 90: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 91: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 92: Matrix on vendor position and classification
            • 10.3 Advanced Instruments LLC
              • Exhibit 93: Advanced Instruments LLC - Overview
              • Exhibit 94: Advanced Instruments LLC - Product / Service
              • Exhibit 95: Advanced Instruments LLC - Key offerings
            • 10.4 Boehringer Ingelheim International GmbH
              • Exhibit 96: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 97: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 98: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 99: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 100: Boehringer Ingelheim International GmbH - Segment focus
            • 10.5 Eppendorf AG
              • Exhibit 101: Eppendorf AG - Overview
              • Exhibit 102: Eppendorf AG - Product / Service
              • Exhibit 103: Eppendorf AG - Key news
              • Exhibit 104: Eppendorf AG - Key offerings
            • 10.6 Lonza Group Ltd.
              • Exhibit 105: Lonza Group Ltd. - Overview
              • Exhibit 106: Lonza Group Ltd. - Business segments
              • Exhibit 107: Lonza Group Ltd. - Key news
              • Exhibit 108: Lonza Group Ltd. - Key offerings
              • Exhibit 109: Lonza Group Ltd. - Segment focus
            • 10.7 Merck KGaA
              • Exhibit 110: Merck KGaA - Overview
              • Exhibit 111: Merck KGaA - Business segments
              • Exhibit 112: Merck KGaA - Key news
              • Exhibit 113: Merck KGaA - Key offerings
              • Exhibit 114: Merck KGaA - Segment focus
            • 10.8 Nova Biomedical Corp.
              • Exhibit 115: Nova Biomedical Corp. - Overview
              • Exhibit 116: Nova Biomedical Corp. - Product / Service
              • Exhibit 117: Nova Biomedical Corp. - Key offerings
            • 10.9 Repligen Corp.
              • Exhibit 118: Repligen Corp. - Overview
              • Exhibit 119: Repligen Corp. - Product / Service
              • Exhibit 120: Repligen Corp. - Key news
              • Exhibit 121: Repligen Corp. - Key offerings
            • 10.10 Sartorius AG
              • Exhibit 122: Sartorius AG - Overview
              • Exhibit 123: Sartorius AG - Business segments
              • Exhibit 124: Sartorius AG - Key news
              • Exhibit 125: Sartorius AG - Key offerings
              • Exhibit 126: Sartorius AG - Segment focus
            • 10.11 Thermo Fisher Scientific Inc.
              • Exhibit 127: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 128: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 129: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 130: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 131: Thermo Fisher Scientific Inc. - Segment focus
            • 10.12 Univercells SA
              • Exhibit 132: Univercells SA - Overview
              • Exhibit 133: Univercells SA - Product / Service
              • Exhibit 134: Univercells SA - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 135: Inclusions checklist
                • Exhibit 136: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 137: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 138: Research methodology
                • Exhibit 139: Validation techniques employed for market sizing
                • Exhibit 140: Information sources
              • 11.5 List of abbreviations
                • Exhibit 141: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Bioprocess Technology Market market growth will increase by $55.84 bn during 2022-2026.
              The bioprocess technology market market is expected to grow at a CAGR of 12.27% during 2022-2026.
              Technavio has segmented the bioprocess technology market market by end-user (Biopharmaceutical companies, Contract manufacturing organizations, Academic research institute, and Others) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Advanced Instruments LLC, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Catalent Inc., Charles River Laboratories International Inc., Corning Inc., Dover Corp., Emerson Electric Co., Fujifilm Diosynth Biotechnologies USA Inc., General Electric Co., Koninklijke Philips NV, Lonza Group Ltd., Merck KGaA, Nova Biomedical Corp., Repligen Corp., Sartorius AG, STADA Arzneimittel AG, Thermo Fisher Scientific Inc., Univercells SA, Eppendorf AG are a few of the key vendors in the bioprocess technology market market.
              North America will register the highest growth rate of 42% among the other regions. Therefore, the bioprocess technology market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the bioprocess technology market market growth are:
              • Increase in infectious diseases
              • Increasing clinical trials in countries
              The bioprocess technology market market vendors should focus on grabbing business opportunities from the biopharmaceutical companies segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>